Have a personal or library account? Click to login
Liver Steatosis and its Implications in Patients with Chronic Viral Hepatitis C Cover

Liver Steatosis and its Implications in Patients with Chronic Viral Hepatitis C

Open Access
|Apr 2023

References

  1. Adinolfi L E, Gambardella M, Andreana A.et al Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001331358–1364.
  2. Clark J M, Brancati F L, Diehl A M. Nonalcoholic fatty liver disease. Gastroenterology 20021221649–1657.
  3. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357(9262):1069–75.
  4. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1Suppl):S47–64.
  5. Bochud PY, Cai T, Overbeck K, et al. Genotype 3 is associated with 2009;51(4):655–66.
  6. Kralj D, Virovic Jukic L, Stojsavljevic S, et al. Hepatitis C Virus, Insulin Resistance, and Steatosis. J Clin Translational Hepatol. 2016;4(1):66–75.
  7. Seronello S, Ito C, Wakita T, Choi J. Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+. J Biol Chem. 2010;285(2): 845–54.
  8. Del Campo JA, Romero-Gomez M. Steatosis and insulin resistance in hepatitis C: a way out for the virus? World J Gastroenterol. 2009;15(40):5014–9.
  9. Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000;33(1):106–15.
  10. Chitturi S, Farrell G C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 20012127–41.
  11. Rubbia-Brandt L, Giostra E, Mentha G, Quadri R, Negro F. Expression of liver steatosis in hepatitis C virus infection and pattern of response to alphainterferon. J Hepatol. 2001;35(2):307.
  12. Bochud PY, Cai T, Overbeck K, et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol. 2009;51(4):655–66.
  13. Sanyal A J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 20021231705–1725
  14. Meissner EG, Lee YJ, Osinusi A, et al. Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients. Hepatology (Baltimore, Md). 2015;61(3):790–801.
  15. Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010;42:503–508.
DOI: https://doi.org/10.2478/inmed-2023-0235 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 17 - 25
Published on: Apr 15, 2023
Published by: Romanian Society of Internal Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2023 Oana Irina Gavril, Irina Mihaela Esanu, Otilia Gavrilescu, Raluca Popa, Maria Luiza Cobzeanu, Diana Tatarciuc, Teodor Vasilcu, Andrei Drugescu, Radu Sebastian Gavril, Florin Mitu, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.